OPKO Health Inc OPK.OQ OPK.O is expected to show a fall in quarterly revenue when it reports results on February 26 for the period ending December 31 2025
The Miami Florida-based company is expected to report a 23.9% decrease in revenue to $139.757 million from $183.6 million a year ago, according to the mean estimate from 7 analysts, based on LSEG data.The company's guidance on October 29 2025, for the period ended December 31, was for revenue between $135.00 million and $140.00 million.
LSEG's mean analyst estimate for OPKO Health Inc is for a loss of 7 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for OPKO Health Inc is $3.00, about 160.9% above its last closing price of $1.15
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Sep. 30 2025 | -0.04 | -0.04 | 0.03 | Beat | 166.7 |
Jun. 30 2025 | -0.10 | -0.11 | -0.19 | Missed | -67.7 |
Mar. 31 2025 | -0.06 | -0.07 | -0.10 | Missed | -45.8 |
Dec. 31 2024 | -0.10 | -0.09 | 0.01 | Beat | 110.7 |
Sep. 30 2024 | -0.09 | -0.09 | -0.09 | Met | 3.6 |
Jun. 30 2024 | -0.11 | -0.09 | -0.01 | Beat | 89.5 |
Mar. 31 2024 | -0.09 | -0.09 | -0.12 | Missed | -26.3 |
Dec. 31 2023 | -0.09 | -0.09 | -0.09 | Met | -2.3 |
This summary was machine generated February 24 at 21:30 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Comments